Immunohematology assists in the screening of blood antigens, Rh factor, plasma, and white blood cell components in the donor blood. It is commonly known as blood banking, which deals with preparation of blood components for transfusion. It aids in reduction of transfusion-related fatalities, such as HIV and thalassemia.
Rising awareness among people in developed as well as developing countries is expected to drive the global immunohematology market in the near future. Increasing health care expenditure and rising worldwide concerns about medical safety are also driving the global immunohematology market. The Asia Pacific region has witnessed gradual adoption of new immunohematology technologies, increasing health care expenditure, and changing dynamics of the in vitro diagnostics industry in the region.

Market Analysis and Insights: Global Immunohematology Market
The global Immunohematology market size is projected to reach US$ 1797.1 million by 2027, from US$ 1376.2 million in 2020, at a CAGR of 3.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunohematology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunohematology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunohematology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunohematology market.

Global Immunohematology Scope and Market Size
Immunohematology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunohematology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunohematology Analyzers and Systems
Immunohematology Reagent

Segment by Application
Blood-Related Diseases
HIV
Hepatitis

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bio-Rad Laboratories
Grifols
Immucor
Ortho Clinical Diagnostic
BD
Beckman Coulter
DIAGAST
Hemo bioscience
Institut de Biotechnologies Jacques Boy
MTC INVITRO
Seqirus
Tulip Group